Clusterin (CLU / Apolipoprotein J)

Clusterin (CLU / Apolipoprotein J)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Clusterin (CLU / Apolipoprotein J)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[CLU](/entities/clu)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P10909" target="_blank">P10909</a></td>
</tr>
<tr>
<td class="label">PDB Structures</td>
<td><a href="https://www.rcsb.org/structure/6RDM" target="_blank">6RDM</a>, <a href="https://www.rcsb.org/structure/9IFM" target="_blank">9IFM</a></td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>75–80 kDa (glycosylated heterodimer)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Secreted (sCLU), cytoplasmic/nuclear (nCLU/iCLU)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Apolipoprotein / extracellular chaperone</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Cerebral Amyloid Angiopathy](/diseases/cerebral-amyloid-angiopathy), Age-Related Macular Degeneration</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<t

Clusterin (CLU / Apolipoprotein J)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Clusterin (CLU / Apolipoprotein J)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[CLU](/entities/clu)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P10909" target="_blank">P10909</a></td>
</tr>
<tr>
<td class="label">PDB Structures</td>
<td><a href="https://www.rcsb.org/structure/6RDM" target="_blank">6RDM</a>, <a href="https://www.rcsb.org/structure/9IFM" target="_blank">9IFM</a></td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>75–80 kDa (glycosylated heterodimer)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Secreted (sCLU), cytoplasmic/nuclear (nCLU/iCLU)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Apolipoprotein / extracellular chaperone</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Cerebral Amyloid Angiopathy](/diseases/cerebral-amyloid-angiopathy), Age-Related Macular Degeneration</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">160 edges</a></td>
</tr>
</table>

Clusterin (CLU / Apolipoprotein J)

Pathway Diagram

Knowledge graph relationships for CLUSTERIN (283 total edges in KG)

Introduction

Clusterin (Clu Apolipoprotein J) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Clusterin (CLU), also known as Apolipoprotein J (ApoJ), complement lysis inhibitor (CLI), testosterone-repressed prostate message 2 (TRPM-2), or sulfated glycoprotein 2 (SGP-2), is a 75–80 kDa secreted heterodimeric glycoprotein encoded by the [clu](/genes/clu) gene on chromosome 8p21.1. [Clusterin is one of the most abundant glycoproteins in cerebrospinal fluid and is expressed widely across tissues, with particularly high levels in the brain, liver, and tes ([May & Bhatt, 2023](https://doi.org/10.3389/fnagi.2023.1167886)).

The CLU gene is the third most significant genetic risk locus for late-onset [alzheimers](/diseases/alzheimers-disease) (LOAD), after [apoe](/proteins/apoe-protein) ([Harold et al., 2009](https://doi.org/10.1038/ng.440); [Lambert et al., 2009](https://doi.org/10.1038/ng.439)). CLU variants may account for approximately 9% of late-onset AD attributable risk. Functionally, clusterin acts as an extracellular molecular chaperone that prevents aggregation of misfolded proteins, modulates complement activation, regulates lipid transport, and influences [Amyloid-Beta](/proteins/amyloid-beta) clearance. The complex biology of clusterin — with distinct isoforms exerting protective versus cytotoxic effects — has made it one of the most intensively studied proteins in neurodegeneration ([Nuutinen et al., 2009](https://doi.org/10.1016/j.brainresrev.2009.05.007)).

Structure and Isoforms

Gene Structure and Processing

The CLU gene spans approximately 18 kb and contains 9 exons. The primary translation product is a 449-amino acid precursor polypeptide that undergoes extensive post-translational processing:

• α-chain (residues 23–227, ~34–36 kDa)
• β-chain (residues 228–449, ~36–39 kDa)

Structural Domains

Clusterin has a distinctive three-domain architecture ([Patel et al., 2025](https://doi.org/10.1038/s41594-025-01631-4)):

• N-terminal domain (β-chain): Contains amphipathic α-helices and coiled-coil motifs reminiscent of small [heat shock proteins](/entities/heat-shock-proteins)
• Central bridge domain: Contains the inter-chain disulfide bonds and intrinsically disordered regions (molten globule domains) that can stabilize stressed protein structures
• C-terminal domain (α-chain): Contains amphipathic helices critical for receptor binding and lipid interaction

Isoforms

| Isoform | Designation | Localization | Function |
|---|---|---|---|
| Secreted clusterin | sCLU | Extracellular, plasma, CSF | Chaperone, complement inhibitor, lipid transport — protective |
| Nuclear clusterin | nCLU | Nucleus | Pro-apoptotic signaling — cytotoxic |
| Intracellular clusterin | iCLU | Cytoplasm, mitochondria | Stress response — context-dependent |

The balance between sCLU and nCLU/iCLU determines whether clusterin exerts neuroprotective or pro-apoptotic effects. AD risk alleles are associated with reduced sCLU expression and enhanced inflammatory profiles ([May & Bhatt, 2023](https://doi.org/10.3389/fnagi.2023.1167886)).

Normal Function

Extracellular Chaperone Activity

Clusterin is one of the few known extracellular chaperones, functionally analogous to intracellular small heat shock proteins. It binds to non-native, misfolded, or aggregation-prone proteins and maintains them in a soluble state suitable for subsequent processing ([Wyatt et al., 2009](https://doi.org/10.1016/j.jmb.2009.04.061)):

• Substrate-binding regions in the IDRs mediate suppression of [Amyloid-Beta](/proteins/amyloid-beta), tau]/proteins/tau], and [alpha-synuclein/proteins/[alpha-synuclein) aggregation
• Does not refold proteins by itself but hands off clients to intracellular chaperones such as [hsp70](/proteins/hsp70) after receptor-mediated endocytosis
• Binding to cell surface receptors (megalin/LRP2, [lrp1](/genes/lrp1) triggers internalization and subsequent lysosomal or proteasomal degradation of chaperone–client complexes

Complement Regulation

Clusterin is a potent inhibitor of the terminal complement cascade:

• Prevents polymerization of C9, thereby blocking assembly of the membrane attack complex (MAC)
• Binds C5b-7, C7, C8, and C9 to sequester complement intermediates
• Protects [neurons](/entities/neurons) and other cells from complement-mediated lysis
• May modulate [microglia](/cell-types/microglia)/cell-types/[microglia](/cell-types/microglia) complement-dependent synaptic pruning

Lipid Transport

As Apolipoprotein J, clusterin participates in lipid metabolism in the CNS:

• Associates with HDL-like particles in cerebrospinal fluid alongside [apoe-protein](/proteins/apoe-protein)
• Transports cholesterol and phospholipids for membrane repair and remodeling
• Facilitates lipid redistribution from damaged to regenerating [neurons](/entities/neurons)
• Cooperates with ABCA1 and [abca7](/entities/abca7) in cholesterol efflux pathways

Additional Functions

• Anti-apoptotic signaling (sCLU): Inhibits Bax activation and cytochrome c release
• Cell adhesion and migration: Interacts with extracellular matrix components
• Sperm maturation: Originally discovered as a major secretory product of Sertoli cells

Role in Disease

Alzheimer's Disease

Clusterin is intimately linked to multiple aspects of AD pathogenesis:

Genetic Risk: GWAS identified CLU as one of the top risk loci for late-onset AD. Key risk SNPs include rs11136000, rs11787077, rs2279590, and rs9331888. [The minor alleles of rs11136000 and rs11787077 are protective, being less frequent in AD patients ([Harold et al., 2009](https://doi.org/10.1038/ng.440)). CLU risk variants are associated with reduced plasma clusterin levels, lower white matter integrity, and faster cognitive decline.

[amyloid-beta](/proteins/amyloid-beta) Interaction: Clusterin is a major [Amyloid-Beta](/proteins/amyloid-beta)-binding protein in CSF and plasma:

• Binds soluble [amyloid-beta](/proteins/amyloid-beta) oligomers and prefibrillar species, influencing their aggregation kinetics
• At sub-stoichiometric concentrations, clusterin can paradoxically accelerate [amyloid-beta](/proteins/amyloid-beta) fibril formation, while at higher concentrations it is protective ([Yerbury et al., 2007](https://doi.org/10.1096/fj.06-7845com))
• Promotes [amyloid-beta](/proteins/amyloid-beta) clearance across the [blood-brain-barrier](/entities/blood-brain-barrier) via megalin/LRP2-mediated transcytosis
• Co-localizes with amyloid plaques in AD brain tissue

Lipid Metabolism: CLU protective variants modulate neuronal excitability through lipid-droplet-mediated neuron-glia communication. Neuronal clusterin promotes lipid droplet formation in [astrocytes](/cell-types/astrocytes), which may buffer lipotoxic stress ([Jin et al., 2025](https://doi.org/10.1186/s13024-025-00840-1)).

Parkinson's Disease

• Elevated clusterin levels in the CSF of PD patients
• Binds [alpha-synuclein](/proteins/alpha-synuclein) oligomers and inhibits their aggregation in vitro
• May modulate alpha-synuclein [prion-like spreading](/mechanisms/prion-like-spreading)

Cerebral Amyloid Angiopathy

• Clusterin co-deposits with [Aβ](/proteins/amyloid-beta) in cerebral vessel walls in CAA
• Influences the balance between parenchymal plaque deposition and vascular amyloid
• CLU variants modulate CAA severity independently of parenchymal AD pathology

Therapeutic Targeting

Clusterin Enhancers

A small molecule secreted clusterin enhancer has been identified that improves memory in AD mouse models by increasing sCLU levels and reducing Aβ burden ([Qi et al., 2025](https://doi.org/10.1038/s44386-025-00009-2)). This approach leverages the protective chaperone function of sCLU.

Biomarker Potential

• Plasma clusterin levels are elevated in AD and correlate with disease severity and brain atrophy
• CSF clusterin reflects CNS-specific changes and may complement Aβ42/40 ratio and p-[tau](/proteins/tau) biomarkers
• CLU genotyping may help stratify patients for clinical trials targeting the complement or lipid pathways

Gene Therapy Approaches

• Adeno-associated virus (AAV)-mediated overexpression of sCLU has shown neuroprotective effects in preclinical AD models
• Targeting the sCLU/nCLU balance may offer a more nuanced therapeutic strategy than simply increasing total clusterin

Background

The study of Clusterin (Clu Apolipoprotein J) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Brain Atlas Resources

• Allen Human Brain Atlas: [Clusterin expression search](https://human.brain-map.org/microarray/search/show?search_term=Clusterin)
• Allen Mouse Brain Atlas: [Clusterin search](https://mouse.brain-map.org/search/index.html?query=Clusterin)
• Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
• BrainSpan Developmental Transcriptome: [Clusterin developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=Clusterin)

See Also

• Amyloid-Beta (Aβ)[/proteins/[Amyloid-Beta
• [apoe-protein](/proteins/apoe-protein)

External Links

• [UniProt: P10909 (CLU_HUMAN)](https://www.uniprot.org/uniprot/P10909)
• [GeneCards: CLU](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLU)
• [ALZFORUM: Clusterin](https://www.alzforum.org/alzpedia/clusterin)
• [Allen Human Brain Atlas: CLU Expression](https://human.brain-map.org/microarray/search/show?search_term=CLU)

Pathway Diagram

The following diagram shows the key molecular relationships involving Clusterin (CLU / Apolipoprotein J) discovered through SciDEX knowledge graph analysis: